Search
Cardiolipin Biosynthesis CL(10:0/10:0/i-19:0/20:0)
smpdb.ca/view/SMP0175829MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(10:0/10:0/i-20:0/23:0)
smpdb.ca/view/SMP0175844MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Efgartigimod alfa
go.drugbank.com/drugs/DB15270ApprovedInvestigational[A243759,A243784] Efgartigimod alfa is a first-in-class[L39501] antagonist of the neonatal Fc receptor (FcRn) used in the treatment of MG. … [L39496] IgG antibodies, including the autoantibodies responsible for MG symptoms, can be 'recycled', a process that significantly extends their half-life by evading lysosomal degradation via binding with
Categories: Human Immunoglobulin GKraurosis Vulvae
go.drugbank.com/conditions/DBCOND0114418Synonyms: Lichen sclerosus et atrophicus, Lichen sclerosus et atropicusMeldonium
go.drugbank.com/drugs/DB13723InvestigationalProducts: SATURID 100 MG/ ML I.V. ENJEKSIYONLUK ÇÖZELTI IÇEREN AMPULNADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial
go.drugbank.com/bio_entities/BE0000081TargetHumansAccessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The ...
Polypeptides: NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrialSolute carrier family 2, facilitated glucose transporter member 10
go.drugbank.com/bio_entities/BE0005220TransporterHumansFacilitative glucose transporter required for the development of the cardiovascular system
Polypeptides: Solute carrier family 2, facilitated glucose transporter member 10Synonyms: GLUT-10, Glucose transporter type 10Von Willebrand factor human
go.drugbank.com/drugs/DB13133ApprovedInvestigationalIt serves a dual role in hemostasis by mediating platelet adhesion and aggregation at the site of blood vessel injury and stabilizing procoagulant factor VIII (FVIII). … The human vWF is used to manage and control bleeding episodes in patients with von Willebrand disease and hemophilia A. It was first approved by the FDA in 2015.
Mixtures: BIOSTATE FOR INJECTION 50 iu/ml, Immunate 250 I.E. FVIII/190 I.E. VWF - Pulver und Lösungsmittel zur Herstellung einer InjektionslösungProducts: IMMUNATE 50 IU/ML POWDER AND SOLVENT FOR SOLUTION FOR INJECTION, IMMUNATE 100 IU/ML POWDER AND SOLVENT FOR SOLUTION FOR INJECTIONCardiolipin Biosynthesis CL(10:0/10:0/i-14:0/i-20:0)
smpdb.ca/view/SMP0175747MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(10:0/10:0/i-16:0/i-20:0)
smpdb.ca/view/SMP0175791MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.